(Q43016416)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20555319%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

title

Cinacalcet hydrochloride treatment significantly improves all-cause and cardiovascular survival in a large cohort of hemodialysis patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20555319%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

main subject

cinacalcet hydrochloride

1 reference

ChEBI release 2020-05-28

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20555319%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

Geoffrey A Block

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20555319%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

David Zaun

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20555319%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Gerard Smits

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20555319%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Martha Persky

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20555319%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Stephanie Brillhart

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20555319%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Kimberly Nieman

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20555319%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Jiannong Liu

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20555319%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

language of work or name

English

0 references

publication date

16 June 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20555319%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20555319%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

78

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20555319%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20555319%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

578-589

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20555319%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/ki.2010.167

5 February 2020

exact match

0 references

cites work

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.167

7 January 2021

Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.167

7 January 2021

Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.167

7 January 2021

Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.167

7 January 2021

Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.167

7 January 2021

Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.167

7 January 2021

Achieving NKF-K/DOQI bone metabolism and disease treatment goals with cinacalcet HCl.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.167

7 January 2021

Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HCl.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.167

7 January 2021

Consistent control of mineral and bone disorder in incident hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.167

7 January 2021

Cinacalcet use patterns and effect on laboratory values and other medications in a large dialysis organization, 2004 through 2006

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.167

7 January 2021

Identifiers

DOI

10.1038/KI.2010.167

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20555319%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference